Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I KinaseLi Zhou(Albert Einstein College of Medicine), Amit Verma(Albert Einstein College of Medicine)Cancer ResearchDecember 29, 201010.1158/0008-5472.can-10-2933Cited by 132SaveCiteExport RISWatch citationsRelated PapersInhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS|Blood|2008|178